EXEFEN IR
-
guaifenesin and
pseudoephedrine hydrochloride tablet
Larken Laboratories, Inc.
----------
ExeFen IRDrug Facts
Guaifenesin 400 mg
Pseudoephedrine HCl 60 mg
Guaifenesin Expectorant
Pseudoephedrine HCl Nasal Decongestant
Temporarily relieves these symptoms associated with a cough, the common cold, hay fever, or other upper respiratory allergies
Do not exceed the recommended dosage
These could be signs of a serious condition.
In case of accidental overdose, get medical help right away.
Store at 20°-25°C (68°-77°F)
croscarmellose sodium, magnesium stearate (veg), microcrystalline cellulose, povidone, sodium starch glycolate, and pregelatinized starch.
Call 1-888-527-5522 weekdays from 9:00 am to 4:00 pm CST or go to http://www.larkenlabs.com.
Figure 1: Container Label
Figure 2
EXEFEN IR
guaifenesin and pseudoephedrine hydrochloride tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part341 | 01/10/2011 |
Labeler - Larken Laboratories, Inc. (791043719) |
Registrant - Larken Laboratories, Inc. (791043719) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Sovereign Pharmaceuticals, LLC | 623168267 | MANUFACTURE |